Evidence for neurogenic inflammation in lichen planopilaris and frontal fibrosing alopecia pathogenic mechanism.
Adult
Aged
Aged, 80 and over
Alopecia
/ pathology
Biopsy
Calcitonin Gene-Related Peptide
/ metabolism
Chronic Disease
Epidermis
/ metabolism
Female
Humans
Immunohistochemistry
Inflammation
Lichen Planus
/ physiopathology
Lipid Metabolism
Lymphocytes
/ pathology
Male
Microscopy, Confocal
Middle Aged
Neurogenic Inflammation
/ pathology
Neuropeptides
/ chemistry
Scalp
/ pathology
Scalp Dermatoses
/ pathology
Substance P
/ metabolism
calcitonin gene-related peptide
nerves
neuropeptide
scarring alopecias
substance P
Journal
Experimental dermatology
ISSN: 1600-0625
Titre abrégé: Exp Dermatol
Pays: Denmark
ID NLM: 9301549
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
04
04
2018
revised:
17
10
2018
accepted:
01
11
2018
pubmed:
9
11
2018
medline:
28
9
2021
entrez:
9
11
2018
Statut:
ppublish
Résumé
Lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) are lymphocytic scarring alopecias affecting primarily the scalp. Although both diseases may share some clinical and histopathological features, in the last decade, FFA has become an "epidemic" particularly in Europe, North and South America with unique clinical manifestations compared to LPP, thus, raising the idea that this disease may have a different pathogenesis. Symptoms such as scalp burning, pruritus or pain are usually present in both diseases, suggesting a possible role for nerves and neuropeptides in the pathogenesis of both diseases. Based on some previous studies, neuropeptides, such as substance P (SP) and calcitonin gene-related peptide (CGRP), have been associated with lipid metabolism and many chronic inflammatory disorders. In this study, we asked if these neuropeptides are associated with LPP and FFA scalp lesions. Alteration in the expression of SP and CGRP in affected and unaffected scalp skin from patients with both diseases was found with examination of sections using immunohistochemical techniques and confocal microscopy. We then quantitatively assessed and compared SP and CGRP expression from control, LPP and FFA scalp biopsies. Although LPP and FFA share similar histopathologic findings, opposite results were found in affected and unaffected scalp in the ELISA tests, suggesting that these diseases may have different pathogenic mechanisms. We also found presence of histopathological inflammation irrespective of evident clinical lesions, which raises the possibility that both diseases may be more generalized processes affecting the scalp.
Substances chimiques
Neuropeptides
0
Substance P
33507-63-0
Calcitonin Gene-Related Peptide
JHB2QIZ69Z
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
282-285Subventions
Organisme : Goltz Professorship, University of Minnesota Department of Dermatology
Pays : International
Informations de copyright
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
S. Kossard, M. S. Lee, B. Wilkinson, J. Am. Acad. Dermatol. 1997, 36, 59.
P. Assouly, P. Reygagne, Semin. Cutan. Med. Surg. 2009, 28, 3.
M. J. Harries, K. Meyer, I. Chaudhry, E. Kloepper, E. Poblet, C. E. Griffiths, R. Paus, J. Pathol. 2013, 231, 236.
J. Bassols, F. J. Ortega, J. M. Moreno-Navarrete, B. Peral, W. Ricart, J. M. Fernández-Real, J. Cell. Biochem. 2009, 107, 1107.
P. Karnik, Z. Tekeste, T. S. McCormick, A. C. Gilliam, V. H. Price, K. D. Cooper, P. Mirmirani, J. Invest. Dermatol. 2009, 129, 1243.
C. Chiang, D. Sah, B. K. Cho, B. E. Ochoa, V. H. Price, J. Am. Acad. Dermatol. 2010, 62, 387.
E. M. Peters, M. E. Ericson, J. Hosoi, K. Seiffert, M. K. Hordinsky, J. C. Ansel, R. Paus, T. E. Scholzen, J. Invest. Dermatol. 1937, 2006, 126.
C. S. Walker, D. L. Hay, S. M. Fitzpatrick, G. J. Cooper, K. M. Loomes, Peptides 2014, 58, 14.
W. J. Lee, H. D. Jung, H. J. Lee, B. S. Kim, S. J. Lee, D. W. Kim, Arch. Dermatol. Res. 2008, 300, 311.
M. Kinori, M. Bertolini, W. Funk, L. Samuelov, K. C. Meyer, V. U. Emelianov, S. Hasse, R. Paus, Exp. Dermatol. 2012, 21, 223.